Genmab and AbbVie Announce Topline Results for Epcoritamab (DuoBody®-CD3xCD20) From Phase 1/2 Trial in Patients with Relapsed/R
13/4 23:25
Company Announcement Based on the topline results from the EPCORE™ NHL-1 clinical trial , Genmab and AbbVie will engage global regulatory authorities to discuss next steps D ata from the clinical trial to be presented at a future medical meeting Large B-cell lymphoma ( LBCL ) is a common form of...